EXEL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $37,555,216.80

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

^$69.39

▲ +3.19 (4.82%)

As of 10/30/2026 04:00 PM ET

Days: 30 | 90 | 365

Exelixis Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/10/2026	Mary C Beckerle	Director	Sell	9,812	$53.66	$526,511.92	16,079
6/1/2026	Jack L Wyszomierski	Director	Sell	3,925	$50.55	$198,408.75	284,384
6/1/2026	Sue Gail Eckhardt	Director	Sell	9,812	$50.14	$491,973.68	16,079
5/26/2026	Dana Aftab	EVP	Sell	43,451	$50.35	$2,187,757.85	594,741
5/20/2026	Patrick J Haley	EVP	Sell	32,110	$49.81	$1,599,399.10	357,638
5/18/2026	Brenda Hefti	SVP	Sell	6,625	$50.21	$332,641.25	106,762
5/18/2026	Christopher J Senner	CFO	Sell	34,901	$50.00	$1,745,050.00	952,317
5/7/2026	George Poste	Director	Sell	60,000	$45.71	$2,742,600.00	118,832
5/7/2026	Maria C. Freire	Director	Sell	20,634	$46.00	$949,164.00	100,819
5/7/2026	Mary C Beckerle	Director	Sell	7,712	$48.45	$373,646.40	17,524
2/24/2026	Dana Aftab	EVP	Sell	47,918	$44.50	$2,132,351.00	616,106
2/19/2026	Dana Aftab	EVP	Sell	29,873	$44.35	$1,324,867.55	664,024
2/18/2026	Brenda Hefti	SVP	Sell	18,669	$44.01	$821,622.69	96,512
2/18/2026	Jack L Wyszomierski	Director	Sell	99,574	$44.01	$4,382,251.74	279,942
2/17/2026	Christopher J Senner	CFO	Sell	30,617	$43.67	$1,337,044.39	976,092
2/17/2026	Patrick J Haley	EVP	Sell	67,814	$43.52	$2,951,265.28	381,908
2/13/2026	Bob Oliver	Director	Sell	30,250	$43.81	$1,325,252.50	21,120
2/13/2026	Christopher J Senner	CFO	Sell	34,278	$43.00	$1,473,954.00	1,042,579
2/13/2026	Sue Gail Eckhardt	Director	Sell	3,856	$43.79	$168,854.24	17,524
11/21/2025	Patrick J Haley	EVP	Sell	28,043	$42.58	$1,194,070.94	374,029
11/20/2025	Patrick J Haley	EVP	Sell	10,000	$42.11	$421,100.00	402,072
11/20/2025	Patrick J Haley	EVP	Sell	34,187	$41.88	$1,431,751.56
11/12/2025	Stelios Papadopoulos	Director	Sell	100,000	$43.55	$4,355,000.00	1,189,228
11/11/2025	Dana Aftab	EVP	Sell	48,383	$42.50	$2,056,277.50	664,778
11/11/2025	Mary C Beckerle	Director	Sell	24,622	$41.93	$1,032,400.46	21,380
6/3/2025	Jack L Wyszomierski	Director	Sell	7,535	$43.09	$324,683.15	358,882
6/2/2025	Sue Gail Eckhardt	Director	Sell	18,838	$42.74	$805,136.12	21,380
5/21/2025	Tomas J. Heyman	Director	Sell	4,544	$44.29	$201,253.76	32,470
5/20/2025	Patrick J Haley	EVP	Sell	34,387	$44.06	$1,515,091.22	412,072
5/16/2025	Amy C Peterson	CMO	Sell	72,776	$45.47	$3,309,124.72	465,393
5/16/2025	Christopher J Senner	CFO	Sell	100,000	$46.00	$4,600,000.00	967,842
5/16/2025	George Poste	Director	Sell	20,634	$45.99	$948,957.66	169,020
5/15/2025	Jeffrey J. Hessekiel	EVP	Sell	25,000	$46.18	$1,154,500.00	693,396
5/15/2025	Patrick J Haley	EVP	Sell	126,383	$47.96	$6,061,328.68	446,459
5/15/2025	Stelios Papadopoulos	Director	Sell	36,508	$44.35	$1,619,129.80	1,279,416
5/14/2025	Patrick J Haley	EVP	Sell	10,000	$42.68	$426,800.00	491,164
5/1/2025	Dana Aftab	EVP	Sell	1,508	$39.00	$58,812.00	693,181
3/3/2025	Patrick J Haley	EVP	Sell	10,000	$38.80	$388,000.00	341,028
2/28/2025	Jack L Wyszomierski	Director	Sell	8,768	$37.80	$331,430.40	356,605
2/28/2025	Jack L Wyszomierski	Director	Sell	8,768	$37.80	$331,430.40	356,605
2/25/2025	Bob Oliver	Director	Sell	18,647	$37.25	$694,600.75	33,514
2/24/2025	Christopher J Senner	CFO	Sell	29,314	$36.14	$1,059,407.96	779,607
2/24/2025	Patrick J Haley	EVP	Sell	52,636	$36.98	$1,946,479.28	303,310
2/14/2025	Mary C Beckerle	Director	Sell	12,210	$34.88	$425,884.80	30,406
11/29/2024	Jeffrey J. Hessekiel	EVP	Sell	60,000	$36.67	$2,200,200.00	486,059
11/22/2024	Patrick J Haley	EVP	Sell	10,000	$35.27	$352,700.00	278,665
11/18/2024	Patrick J Haley	EVP	Sell	41,588	$34.36	$1,428,963.68	288,665
11/5/2024	Dana Aftab	EVP	Sell	96,986	$35.00	$3,394,510.00	498,945
11/1/2024	George Poste	Director	Sell	30,000	$34.00	$1,020,000.00	169,020
11/1/2024	Jeffrey J. Hessekiel	EVP	Sell	50,000	$34.13	$1,706,500.00	530,325
10/30/2024	Dana Aftab	EVP	Sell	1,162	$31.40	$36,486.80	498,945
10/28/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$28.39	$709,750.00	580,325
9/23/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$26.38	$659,500.00	605,325
8/26/2024	Jeffrey J. Hessekiel	EVP	Sell	20,000	$25.79	$515,800.00	630,325
8/14/2024	Maria C. Freire	Director	Sell	8,250	$26.56	$219,120.00	91,007
8/12/2024	Dana Aftab	EVP	Sell	20,883	$27.06	$565,093.98	500,107
8/9/2024	Christopher J Senner	CFO	Sell	125,000	$27.19	$3,398,750.00	721,680
8/8/2024	George Poste	Director	Sell	33,725	$26.89	$906,865.25	199,020
8/7/2024	Dana Aftab	EVP	Sell	95,000	$25.00	$2,375,000.00	520,990
6/4/2024	Jack L Wyszomierski	Director	Sell	8,287	$22.00	$182,314.00	349,499
5/30/2024	David Edward Johnson	Director	Buy	225,000	$20.76	$4,671,000.00	1,525,730
5/28/2024	David Edward Johnson	Director	Buy	200,000	$20.32	$4,064,000.00	1,300,730
5/21/2024	George Poste	Director	Sell	11,686	$20.96	$244,938.56	213,907
5/13/2024	Jack L Wyszomierski	Director	Sell	10,923	$21.37	$233,424.51	338,948
3/21/2024	Alan M. Garber	Director	Sell	19,205	$24.01	$461,112.05	35,703
2/23/2024	Patrick J Haley	EVP	Sell	47,020	$21.45	$1,008,579.00	384,866
2/21/2024	David Edward Johnson	Director	Buy	190,000	$20.70	$3,933,000.00	1,100,730
12/14/2023	Patrick J Haley	EVP	Sell	50,000	$23.35	$1,167,500.00	307,687
12/12/2023	Patrick J Haley	EVP	Sell	14,149	$22.50	$318,352.50	307,687
12/4/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.06	$551,500.00	558,345
11/30/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.01	$550,250.00	583,345
11/27/2023	David Edward Johnson	Director	Buy	120,409	$21.61	$2,602,038.49	910,730

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

85.27% of Exelixis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/31/2026	Chicago Partners Investment Group LLC	19,376	$1.25M	0.0%	+3.3%	0.008%
10/31/2026	Covestor Ltd	791	$46K	0.0%	-36.6%	0.000%
10/31/2026	Ascent Group LLC	6,840	$0.40M	0.0%	-11.6%	0.003%
10/30/2026	Provenance Wealth Advisors LLC	1,020	$60K	0.0%	N/A	0.000%
10/30/2026	Oregon Public Employees Retirement Fund	51,368	$3M	0.0%	-1.2%	0.021%
10/30/2026	Tucker Asset Management LLC	9,530	$0.56M	0.1%	N/A	0.004%
10/30/2026	Signature Equity Partners LLC	4,134	$0.24M	0.1%	+194.0%	0.002%
10/30/2026	Capital Management Corp VA	158,325	$9.25M	1.4%	-1.9%	0.064%
10/29/2026	Greenleaf Trust	4,363	$0.26M	0.0%	-4.3%	0.002%
10/29/2026	Sumitomo Mitsui Trust Group Inc.	49,118	$2.87M	0.0%	-3.7%	0.020%
10/29/2026	Mirae Asset Global Investments Co. Ltd.	23,999	$1.40M	0.0%	N/A	0.010%
10/29/2026	Profund Advisors LLC	42,521	$2.48M	0.1%	+36.0%	0.017%
10/29/2026	ProShare Advisors LLC	18,007	$1.05M	0.0%	-0.8%	0.007%
10/29/2026	Vise Technologies Inc.	27,248	$1.59M	0.0%	+73.5%	0.011%
10/29/2026	Moss Adams Wealth Advisors LLC	5,423	$0.32M	0.0%	N/A	0.002%
10/28/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	97,999	$5.72M	0.0%	+5.2%	0.040%
10/28/2026	Soltis Investment Advisors LLC	4,868	$0.28M	0.0%	+7.0%	0.002%
10/28/2026	China Universal Asset Management Co. Ltd.	45,210	$2.65M	0.1%	+13.0%	0.000%
10/28/2026	Childress Capital Advisors LLC	5,471	$0.32M	0.0%	+10.6%	0.000%
10/28/2026	BOKF NA	55,757	$3.26M	0.0%	+1.0%	0.000%
10/28/2026	Motley Fool Asset Management LLC	9,539	$0.56M	0.0%	+9.5%	0.000%
10/28/2026	North Dakota State Investment Board	7,607	$0.44M	0.0%	-2.9%	0.000%
10/28/2026	VestGen Advisors LLC	8,887	$0.52M	0.0%	-33.9%	0.000%
10/27/2026	Laurel Wealth Advisors LLC	3,000	$0.18M	0.0%	N/A	0.001%
10/27/2026	Roman Butler Fullerton & Co.	168,589	$9.85M	2.2%	N/A	0.068%
10/26/2026	Park Avenue Securities LLC	15,761	$0.92M	0.0%	-4.7%	0.006%
10/26/2026	Verdence Capital Advisors LLC	8,097	$0.47M	0.0%	N/A	0.003%
10/26/2026	National Wealth Management Group LLC	9,902	$0.58M	0.2%	N/A	0.004%
10/26/2026	WealthCare Asset Management LLC	27,214	$1.59M	1.4%	N/A	0.011%
10/24/2026	EULAV Asset Management	432,060	$25.24M	0.9%	-9.2%	0.174%
10/23/2026	Signaturefd LLC	9,400	$0.55M	0.0%	+30.8%	0.004%
10/23/2026	Citizens Financial Group Inc. RI	8,459	$0.49M	0.0%	-3.8%	0.003%
10/23/2026	Sowell Financial Services LLC	9,010	$0.53M	0.0%	+78.7%	0.004%
10/23/2026	Evergreen Capital Management LLC	15,183	$0.89M	0.0%	-1.5%	0.006%
10/23/2026	Fifth Third Wealth Advisors LLC	9,511	$0.56M	0.0%	+5.1%	0.004%
10/23/2026	Sterling Capital Management LLC	56,605	$3.31M	0.1%	+254.8%	0.023%
10/23/2026	Inspire Investing LLC	84,097	$4.91M	0.2%	+5.7%	0.034%
10/22/2026	Yousif Capital Management LLC	67,029	$3.92M	0.0%	-7.5%	0.027%
10/22/2026	Brookstone Capital Management	19,260	$1.13M	0.0%	+20.2%	0.008%
10/22/2026	Root Financial Partners LLC	2,384	$0.14M	0.0%	N/A	0.001%
10/21/2026	Crossmark Global Holdings Inc.	73,013	$4.27M	0.1%	-2.4%	0.029%
10/21/2026	Sowell Financial Services LLC	9,010	$0.53M	0.0%	+78.7%	0.004%
10/21/2026	Quadrant Capital Group LLC	29,006	$1.73M	0.0%	-4.0%	0.012%
10/21/2026	Eagle Harbor Asset Management Inc. ADV	24,504	$1.43M	1.1%	-4.3%	0.010%
10/21/2026	Nisa Investment Advisors LLC	108,670	$6.35M	0.0%	+195.6%	0.044%
10/21/2026	Robeco Institutional Asset Management B.V.	822,375	$48.04M	0.1%	-20.1%	0.332%
10/20/2026	Cypress Capital LLC	13,811	$0.81M	0.2%	-6.3%	0.006%
10/20/2026	CWA Asset Management Group LLC	67,607	$3.95M	0.1%	+7.0%	0.027%
10/19/2026	Novem Group	23,005	$1.34M	0.1%	-1.0%	0.009%
10/17/2026	IFP Advisors Inc	62,529	$3.65M	0.1%	+45.1%	0.025%
10/17/2026	Center For Asset Management LLC	9,048	$0.53M	0.2%	-19.7%	0.004%
10/16/2026	TD Waterhouse Canada Inc.	6,959	$0.40M	0.0%	-7.7%	0.003%
10/16/2026	Annex Advisory Services LLC	29,572	$1.73M	0.0%	+14.1%	0.012%
10/16/2026	Goldstein Advisors LLC	3,859	$0.23M	0.0%	N/A	0.002%
10/16/2026	Milestone Asset Management LLC	200,127	$11.69M	1.9%	+581.0%	0.081%
10/15/2026	Davidson Capital Management Inc.	127,973	$7.48M	1.3%	+0.8%	0.052%
10/15/2026	Assenagon Asset Management S.A.	131,914	$7.71M	0.0%	-69.2%	0.053%
10/15/2026	Brindle & Bay Financial Advisors LLC	4,105	$0.24M	0.1%	+8.0%	0.002%
10/15/2026	State of Alaska Department of Revenue	35,614	$2.08M	0.0%	-3.1%	0.014%
10/15/2026	Curated Wealth Partners LLC	7,504	$0.44M	0.0%	-63.0%	0.003%
10/15/2026	Winnacle Wealth LLC	16,994	$0.99M	0.6%	-11.1%	0.007%
10/15/2026	Mather Group LLC.	757	$44K	0.0%	+124.6%	0.000%
10/14/2026	Mezzasalma Advisors LLC	19,194	$1.12M	0.2%	-13.1%	0.008%
10/14/2026	MinichMacGregor Wealth Management LLC	110,642	$6.46M	1.1%	N/A	0.045%
10/14/2026	Signal Advisors Wealth LLC	5,012	$0.29M	0.0%	N/A	0.002%
10/14/2026	Ifrah Financial Services Inc.	19,654	$1.15M	0.3%	N/A	0.008%
10/14/2026	B. Riley Wealth Advisors Inc.	5,633	$0.33M	0.0%	N/A	0.002%
10/14/2026	Krilogy Financial LLC	19,391	$1.16M	0.0%	-8.0%	0.008%
10/14/2026	RHS Financial LLC	12,159	$0.71M	0.2%	-4.9%	0.005%
10/9/2026	Balefire LLC	6,855	$0.40M	0.1%	-3.4%	0.003%
10/9/2026	Wedmont Private Capital	8,940	$0.53M	0.0%	+7.2%	0.004%
10/9/2026	Post Resch Tallon Group Inc.	8,428	$0.49M	0.3%	-83.3%	0.003%
10/9/2026	Monument Capital Management	82,041	$4.79M	1.0%	+1.3%	0.033%
10/9/2026	GAMMA Investing LLC	12,227	$0.71M	0.0%	+10.9%	0.005%
10/8/2026	Farther Finance Advisors LLC	18,290	$1.07M	0.0%	+29.1%	0.007%
10/8/2026	CoreCap Advisors LLC	12,114	$0.71M	0.0%	+79.3%	0.005%
10/8/2026	Apella Capital LLC	4,272	$0.25M	0.0%	N/A	0.002%
10/7/2026	Steph & Co.	2,548	$0.15M	0.0%	-6.9%	0.001%
10/5/2026	MassMutual Private Wealth & Trust FSB	1,480	$86K	0.0%	-12.8%	0.001%
10/2/2026	CX Institutional	2,145	$0.13M	0.0%	-97.6%	0.001%
10/2/2026	Private Client Services LLC	28,539	$1.67M	0.5%	+0.7%	0.012%
9/23/2026	QRG Capital Management Inc.	20,356	$1.11M	0.0%	+11.5%	0.008%
9/23/2026	Envestnet Portfolio Solutions Inc.	4,791	$0.26M	0.0%	N/A	0.002%
9/23/2026	Envestnet Asset Management Inc.	949,669	$51.67M	0.0%	+210.9%	0.383%
9/22/2026	State Street Corp	9,970,071	$542.47M	0.0%	-3.2%	4.024%
9/9/2026	The Manufacturers Life Insurance Company	181,540	$9.88M	0.0%	-1.4%	0.073%
9/9/2026	Sequoia Financial Advisors LLC	20,292	$1.10M	0.0%	+59.7%	0.008%
9/9/2026	Tidal Investments LLC	375,316	$20.42M	0.0%	-1.8%	0.151%
9/9/2026	Archford Capital Strategies LLC	13,038	$0.71M	0.1%	N/A	0.005%
9/9/2026	Krensavage Asset Management LLC	370,693	$20.17M	7.7%	-10.8%	0.150%
9/9/2026	WINTON GROUP Ltd	99,834	$5.43M	0.2%	+1,651.5%	0.040%
9/9/2026	Engineers Gate Manager LP	110,353	$6M	0.1%	-32.5%	0.045%
9/9/2026	Pinnacle Wealth Management Advisory Group LLC	4,801	$0.26M	0.0%	-7.6%	0.002%
9/9/2026	Integrated Wealth Concepts LLC	58,636	$3.19M	0.0%	-25.7%	0.024%
9/9/2026	NewEdge Advisors LLC	32,532	$1.77M	0.0%	-4.3%	0.013%
9/9/2026	IFP Advisors Inc	43,101	$2.35M	0.0%	-0.8%	0.017%
9/9/2026	Squarepoint Ops LLC	473,707	$25.77M	0.0%	+1,649.8%	0.191%
9/9/2026	Baird Financial Group Inc.	437,138	$23.79M	0.0%	+7,459.0%	0.176%
9/9/2026	Arcus Capital Partners LLC	5,662	$0.31M	0.1%	-3.6%	0.002%
9/8/2026	Allworth Financial LP	10,562	$0.58M	0.0%	+4.7%	0.004%

Data available starting January 2016

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. It develops zanzalintinib, a novel, potent, next-generation oral tyrosine kinase inhibitor (TKI) that targets VEGF receptors, MET and the TAM kinases (TYRO3, AXL and MER); and XB002, a next-generation tissue factor (TF)-targeting ADC, administered via intravenous infusion and composed of a human monoclonal antibody (mAb) against TF that is conjugated to an auristatin-based microtubulin inhibitor (MTI) payload. It has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited, as well as clinical development agreement with Sairopa B.V. for ADU-1805. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Today's Range

Now: $69.39

$67.05

$72.10

50 Day Range

MA: $59.39

$54.08

$69.39

52 Week Range

Now: $69.39

$36.00

$72.10

Volume

5,071,817 shs

Average Volume

2,257,691 shs

Market Capitalization

$17.19 billion

P/E Ratio

20.78

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of Exelixis?: Exelixis' top insider shareholders include:
George A Scangos (Director)
David Edward Johnson (Director)
Stelios Papadopoulos (Director)
Christopher J Senner (CFO)
Michael Morrissey (CEO)
Jeffrey Hessekiel (EVP)
Dana Aftab (EVP)
Lance Willsey (Director)
Patrick J Haley (EVP)
Amy C Peterson (CMO)
Learn More about top insider investors at Exelixis.
Who are the major institutional investors of Exelixis?: Exelixis' top institutional investors include:
Robeco Institutional Asset Management B.V. — 0.33%
EULAV Asset Management — 0.17%
Milestone Asset Management LLC — 0.08%
Roman Butler Fullerton & Co. — 0.07%
Capital Management Corp VA — 0.06%
Assenagon Asset Management S.A. — 0.05%
Learn More about top institutional investors of Exelixis stock.
Which major investors are selling Exelixis stock?: During the previous quarter, EXEL stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Robeco Institutional Asset Management B.V.
CX Institutional
EULAV Asset Management
Post Resch Tallon Group Inc.
Curated Wealth Partners LLC
Yousif Capital Management LLC
VestGen Advisors LLC
Within the previous year, company insiders that have sold Exelixis company stock include:
Stelios Papadopoulos (Director)
Christopher J Senner (CFO)
Dana Aftab (EVP)
Patrick J Haley (EVP)
Jack L Wyszomierski (Director)
George Poste (Director)
Brenda Hefti (SVP)
Maria C Freire (Director)
Mary C Beckerle (Director)
Bob Oliver (Director)
Sue Gail Eckhardt (Director)
Learn More investors selling Exelixis stock.
Which major investors are buying Exelixis stock?: In the previous quarter, EXEL stock was acquired by institutional investors including:
Milestone Asset Management LLC
Roman Butler Fullerton & Co.
MinichMacGregor Wealth Management LLC
Nisa Investment Advisors LLC
Sterling Capital Management LLC
WealthCare Asset Management LLC
Mirae Asset Global Investments Co. Ltd.
Ifrah Financial Services Inc.